Adenosine A2a Receptor-Mediated Neuroinflammation in Remote Ischemic Conditioning for Post-Stroke Sleep Disorders
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 136 participants.
Also called NCT07874594
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 136 participants
- Registry
-
NCT07874594
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07874594. Randomized; double masking; primary purpose treatment. Start 2026-09-01 (actual); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Adenosine A2a Receptor-Mediated Neuroinflammation in Remote Ischemic Conditioning for Post-Stroke Sleep Disorders
- Acronym
- RIC-A2AR-SD
- Condition
- Insomnia
- Condition
- Ischemic Stroke
- Condition
- Sleep Wake Disorders
- Intervention (Device)
- RIC Intervention Group
- Intervention (Device)
- Sham Control Group
- Lead sponsor
- Sichuan Academy of Medical Sciences
Record details
- Record id
cardio:ct-nct07874594- Content hash
36fdfc92f2e5af4106533e079b5e7affd3ae1e0d1b08b2f03451649197101446